№ US20260000767A1発明
審査中FORMULATIONS OF BENDAMUSTINE
FORMULATIONS OF BENDAMUSTINE
Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed. The methods conveniently allow shorter administration time without the active ingredient coming out of solution as compared to presently available formulations.
❖Eagle Pharmaceuticals, Inc.Srikanth Sundaram§ 2/20 請求項A61K 47/10, A61K 9/, A61K 31/4184 +310